Henry Rodriguez
Pediatric Endocrinology · Tampa, FLNPI 1962434662
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $161,791 of the $211,074 with a category attached, or 76.7%. Sanofi-aventis U.S. LLC accounts for 85.7% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $81,147, more than ten times the $5,246 reported in 2019. Among pediatric endocrinology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 172 payments — averaging $1227.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$181K
- Merck$25K
- Mannkind Corporation$2K
- Eli Lilly$1K
- Novo Nordisk$226
- Medtronic$191
- plus $1K from 10 others
Across 1,044 payments — averaging $1456.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$903K
- Boehringer Ingelheim$167K
- Eli Lilly$148K
- Novo Nordisk AS$110K
- Mannkind Corporation$73K
- Boehringer Ingelheim Pharma GmbH & Co.kg$45K
- plus $74K from 3 others
What the payments were for
- Consulting fees$30,98815%
- Speaking & faculty fees$161,79177%
- Travel & lodging$13,6526%
- Food & beverage$4,5712%
- Education$730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 123 | $180,922 |
| Merck | 15 | $24,985 |
| Mannkind Corporation | 6 | $2,440 |
| Eli Lilly | 6 | $1,250 |
| Novo Nordisk | 7 | $226 |
| Medtronic(2 entities) | 5 | $191 |
| Sequel Med Tech, LLC | 1 | $156 |
| BETA Bionics, Inc. | 1 | $145 |
| Neurocrine Biosciences, Inc. | 1 | $134 |
| Tandem Diabetes Care, Inc. | 1 | $126 |
| AstraZeneca | 1 | $125 |
| AbbVie | 1 | $121 |
| Ascendis Pharma Endocrinology Inc | 1 | $97 |
| Dexcom, Inc. | 1 | $84 |
| Senseonics, Incorporated | 1 | $41 |
| Ultragenyx Pharmaceutical Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$159,321
- STEGLATRO$12,041
- JANUVIA$7,331
- AFREZZA$2,240
- JANUMET$1,488
- HUMALOG$1,158
- iLet Bionic Pancreas$434
- TWIIST$156
- iLet Insulin Infusion Kit Inset$145
- iLet Insulin Infusion Kit Contact Detach$145
- MINIMED 780G$140
- CRENESSITY$134
- t:slim X2 Insulin Pump with Control-IQ$126
- Strensiq$125
- Lupron Depot$121
How this compares
$211,074 in reported general payments places this provider in the 95th percentile of 102 pediatric endocrinology providers in Florida.
Other pediatric endocrinology in Tampa
- Dorothy ShulmanTampa$104K
- Danielle ReynoldsTampa$8K
- Terry DeclueTampa$6K
- Grace DouganTampa$6K
- Tsu-Hui LinTampa$3K
- Joshua YangOrlando$846K
- Michael HallerGainesville$102K
- Alejandro DiazMiami$101K
- Samuel FreedmanPembroke Pines$71K
- Jennifer MillerGainesville$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.